Search in:

Advanced search

Diabetes, Metabolic Syndrome and Obesity Volume 8, 2015 - Issue

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Original Research

Withdrawal of sulfonylureas from patients with type 2 diabetes receiving long-term sulfonylurea and insulin combination therapy results in deterioration of glycemic control: a randomized controlled trial

Weerachai Srivanichakorn1 Division of Ambulatory Medicine, Mahidol University, Thailand

Apiradee Sriwijitkamol2 Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Thailand

Aroon Kongchoo2 Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Thailand

Sutin Sriussadaporn2 Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Thailand

Nattachet Plengvidhya2 Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Thailand

Raweewan Lertwattanarak2 Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Thailand

Sathit Vannasaeng2 Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Thailand

Nuntakorn Thongtang2 Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, ThailandCorrespondence[email protected]

show all

Pages 137-145 | Published online: 02 Mar 2015

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

No authors listedIntensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) GroupLancet19983529131837 8539742976
PubMed Web of Science ®Google Scholar
WrightABurdenACPaiseyRBCullCAHolmanRRSulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the UK Prospective Diabetes Study (UKPDS 57)Diabetes Care2002252330 33611815505
PubMed Web of Science ®Google Scholar
RodbardHWJellingerPSDavidsonJAStatement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic controlEndocr Pract2009156540 55919858063
PubMed Web of Science ®Google Scholar
McGillJBSelecting among ADA/EASD tier 1 and tier 2 treatment optionsJ Fam Pract2009589 Suppl TreatingS26 S3419744422
PubMed Web of Science ®Google Scholar
InzucchiSEBergenstalRMBuseJBManagement of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Diabetes Care20123561364 137922517736
PubMed Web of Science ®Google Scholar
HarperWClementMGoldenbergRCanadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada: pharmacologic management of type 2 diabetesCan J Diabetes201337Suppl 1S61 S6824070965
PubMed Web of Science ®Google Scholar
Landstedt-HallinLArnerPLinsPEBolinderJOlsenHGroopLThe role of sulphonylurea in combination therapy assessed in a trial of sulphonylurea withdrawal. Scandinavian Insulin-Sulphonylurea Study Group Research TeamDiabet Med19991610827 83410547209
PubMed Web of Science ®Google Scholar
Nyback-NakellAAdamsonULinsPELandstedt-HallinLGlycaemic responsiveness to long-term insulin plus sulphonylurea therapy as assessed by sulphonylurea withdrawalDiabet Med200724121424 142917976204
PubMed Web of Science ®Google Scholar
AbrairaCHendersonWGColwellJAResponse to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM)Diabetes Care1998214574 5799571345
PubMed Web of Science ®Google Scholar
LevyJCMatthewsDRHermansMPCorrect homeostasis model assessment (HOMA) evaluation uses the computer programDiabetes Care199821122191 21929839117
PubMed Web of Science ®Google Scholar
MatsudaMDeFronzoRAInsulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clampDiabetes Care19992291462 147010480510
PubMed Web of Science ®Google Scholar
SoonthornpunSSetasubanWThamprasitAChayanunnukulWRattarasarnCGeaterANovel insulin sensitivity index derived from oral glucose tolerance testJ Clin Endocrinol Metab20038831019 102312629079
PubMed Web of Science ®Google Scholar
Ravnik-OblakMMrevljeFInsulin versus a combination of insulin and sulfonylurea in the treatment of NIDDM patients with secondary oral failureDiabetes Res Clin Pract199530127 358745203
PubMed Web of Science ®Google Scholar
Del PratoSPulizziNThe place of sulfonylureas in the therapy for type 2 diabetes mellitusMetabolism2006555 Suppl 1S20 S2716631807
PubMed Web of Science ®Google Scholar
GutniakMKarlanderSGEfendicSGlyburide decreases insulin requirement, increases beta-cell response to mixed meal, and does not affect insulin sensitivity: effects of short- and long-term combined treatment in secondary failure to sulfonylureaDiabetes Care1987105545 5542890501
PubMed Web of Science ®Google Scholar
LundershausenROrbanSPissarekDPanzramGLong-term effect of combination glibenclamide-insulin treatment in the secondary failure of sulfonylurea therapy – results of a one-year double blind studyWien Klin Wochenschr19879917603 608 German3118579
PubMed Web of Science ®Google Scholar
NauckMADuranSKimDA comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority studyDiabetologia2007502259 26717160407
PubMed Web of Science ®Google Scholar
PughJAWagnerMLSawyerJRamirezGTuleyMFriedbergSJIs combination sulfonylurea and insulin therapy useful in NIDDM patients? A metaanalysisDiabetes Care1992158953 9591387073
PubMed Web of Science ®Google Scholar
JohnsonJLWolfSLKabadiUMEfficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trialsArch Intern Med19961563259 2648572835
PubMedGoogle Scholar
Nyback-NakellAAdamsonULinsPELandstedt-HallinLAdding glimepiride to insulin + metformin in type 2 diabetes of more than 10 years’ duration – a randomised, double-blind, placebo-controlled, cross-over studyDiabetes Res Clin Pract20141032286 29124485398
PubMed Web of Science ®Google Scholar
Meyer Zu SchwabedissenHEBottcherKSteinerTOATP1B3 is expressed in pancreatic beta-islet cells and enhances the insulinotropic effect of the sulfonylurea derivative glibenclamideDiabetes2014632775 78424150606
PubMed Web of Science ®Google Scholar
HarrisonLBAdams-HuetBRaskinPLingvayIBeta-cell function preservation after 3.5 years of intensive diabetes therapyDiabetes Care20123571406 141222723578
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Withdrawal of sulfonylureas from patients with type 2 diabetes receiving long-term sulfonylurea and insulin combination therapy results in deterioration of glycemic control: a randomized controlled trial

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Withdrawal of sulfonylureas from patients with type 2 diabetes receiving long-term sulfonylurea and insulin combination therapy results in deterioration of glycemic control: a randomized controlled trial

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date